Business Standard

Monday, January 20, 2025 | 06:19 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Saint-Gobain Sekurit India Ltd News

HUL Q3 preview: Analysts see muted quarter; PAT may rise 2% YoY, revenue 1%

Analysts and investors will eye HUL's outlook on demand and growth

HUL Q3 preview: Analysts see muted quarter; PAT may rise 2% YoY, revenue 1%
Updated On : 20 Jan 2025 | 4:57 PM IST
Updated On : 20 Jan 2025 | 4:50 PM IST
Updated On : 20 Jan 2025 | 4:50 PM IST
Updated On : 20 Jan 2025 | 4:50 PM IST
Updated On : 20 Jan 2025 | 4:31 PM IST
Updated On : 20 Jan 2025 | 4:31 PM IST

Dr Reddy's Labs Q3 Preview: Revlimid to dent US sales, profits may rise 12%

Indian pharmaceutical (IT) major, Dr Reddy's Laboratories, is scheduled to deliver its October-December quarterly earnings for the financial year 2024-25 (Q3FY25) on Thursday, January 23, 2025

Dr Reddy's Labs Q3 Preview: Revlimid to dent US sales, profits may rise 12%
Updated On : 20 Jan 2025 | 4:23 PM IST
Updated On : 20 Jan 2025 | 4:04 PM IST